Host protection from infection relies on the recognition of pathogens by innate pattern recognition receptors such as Toll-like receptors (TLRs). Here we show that the orphan receptor TLR13 in mice recognizes a conserved 23S ribosomal RNA (rRNA) sequence that is the binding site of macrolide, lincosamide, and streptogramin group (MLS) antibiotics (including erythromycin) in bacteria. Notably, 23S rRNA from clinical isolates of erythromycin-resistant S. aureus and synthetic oligoribonucleotides carrying methylated adenosine or a guanosine mimicking a MLS resistance-causing modification failed to stimulate TLR13. Our results thus reveal both a natural TLR13 ligand and specific mechanisms of antibiotic resistance as potent bacterial immune evasion strategy, avoiding recognition via TLR13.
Whereas TLR2, TLR4 and TLR9 are major host sensors of Gramnegative bacteria and TLR2 is thought to be the central detector of Gram-positive bacteria, other pattern recognition receptors (PRRs) such as TLR7 contribute to bacteria sensing, too (1) (2) (3) (4) (5) (6) (7) . The high sensitivity of mice lacking expression of these TLRs to Gram-positive bacteria, however, implies that other TLRs or members of other classes of pattern recognition receptors (PRRs) such as C-type lectins, RIG-I-like helicases (RLHs), or nucleotide binding domain-and leucine-rich repeatcontaining proteins (NLRs) play a role in the detection of Gram-positive bacteria. We therefore compared the responsiveness of macrophages lacking the expression of molecules that signal downstream of these PRRs, including caspase recruitment domain (CARD) 9, receptorinteracting protein 2 (RIP2), apoptosis-associated speck-like protein containing a CARD (ASC), interleukin (IL)-1 receptor 1, IL-18, or MyD88, to heat inactivated S. aureus (hiSa) or Streptococcus pneumoniae (both Gram-positive) in the presence of a TLR2-blocking antibody (2, (8) (9) (10) . Cytokine production was found to strictly depend on MyD88 ( fig. S1A ), which suggested that TLRs rather than RLHs or NLRs are responsible for the detection of these bacteria. Moreover, analysis of ectopically expressed RLH function indicated a lack of RLH involvement in Gram-positive bacteria sensing (fig. S1B).
Next we asked whether endosomal TLRs (TLR3, -7, -8, -9, -11, and -13) are involved in cell activation. We inhibited endosomal acidification with bafilomycin and analyzed UNC93B1-mutant (3D) macrophages that lack endoplasmic reticulum-endosome TLR trafficking and are susceptible to S. aureus infection (2, 11, 12) . Bafilomycin treatment abrogated recognition of Gram-positive bacteria in Tlr2 -/-macrophages (Fig.  1A) . Furthermore, 3D/Tlr2/4 -/-and 3D/Tlr2 -/-mice or corresponding macrophages (but not those generated from 3D mice unless TLR2 was blocked), were unresponsive to Grampositive bacterial challenge (Fig. 1, B  and C, and fig. S1C ). Unexpectedly,
Tlr23479
-/-macrophages (or mice) responded well to hiSa challenge unless the bacterial preparations were subjected to RNase A treatment, which did not impair TLR2-driven activation of wt controls, or endosomal TLR function was abrogated (Fig. 1, D-F) . These data suggested that an endosomal RNA sensor besides TLR3 and TLR7 can act as cellular detector of hiSa.
Dendritic cell (DC) subsets express different sets of TLRs (13) . We generated bone marrow-derived conventional (c) DC and plasmacytoid (p) DC in vitro. The responsiveness of these cells to hiSa was dependent on MyD88 and UNC93B1. Specifically, Tlr23479
high (expressing TLR11, -12, -13) and signal regulatory protein α (Sirp) high cDCs (expressing TLR13 but lacking TLR11, -12) responded to hiSa, whereas Tlr23479 -/-pDCs (expressing TLR12 but lacking TLR11, -13) failed to do so (Fig. 1G) . Together, these findings implied that TLR13 acts as bacterial single-stranded (ss) RNA sensor, even though TLR13 has recently been linked with the recognition of vesicular stomatitis virus (14) .
To identify the relevant RNA, we incubated hiSa with calf intestinal phosphatase, 5′-phosphate-specific phosphatase (to affect the integrity of 16S and 23S rRNA), or double-stranded (ds) RNA-specific RNase III or VI. These treatments did not alter the stimulatory activity of hiSa, in line with a recent report ( fig. S2 , A-C) (15) . However, ssRNA-specific RNase A treatment abrogated the Tlr23479 -/-cDC (and macrophage) stimulatory activity of hiSa as did nucleic acid-degrading benzonase (Fig. 1, D , E, and G; and fig. S2B , please note that Flt3L-expanded CD8 + cDCs do not produce IL-12p70 in response to TLR2 ligands that are contained in hiSa (16)). We then treated total RNA with 5′-phosphate-dependent exonuclease (to degrade specifically large rRNAs, namely 16S and 23S rRNA) and purified large rRNAs ( fig. S2C ) to narrow down the stimulatory activity. After transfection, large rRNA isolates of both S. aureus and E. coli triggered the activation of Tlr23479 -/-macrophages and cDCs while 16S/23S rRNA digestion abrogated stimulatory activity ( Fig. 2A) . Accordingly, low molecular weight (lmw) portions from total RNA lacked stimulatory activity, whereas high molecular weight (hmw) portions of Gram-positive and Gram-negative bacterial RNA activated Tlr23479 -/-cells ( Fig. 2B and fig. S2 , D and E). These findings suggested that a fraction of large bacterial rRNAs activates macrophages and cDCs in a MyD88-dependent manner. We assume that the increased RNA-driven activation of Tlr23479 To analyze if rRNA modifications induced in antibiotic resistant strains by antibiotic treatment (e.g., with erythromycin (17, 18) ) would modify the immunostimulatory capacity of rRNA we applied five clinical S. aureus isolates displaying various resistance phenotypes, including erythromycin resistance. Isolates grown in the presence of erythromycin largely lacked the capacity to activate Tlr23479 -/-macrophages and induced lower amounts of serum cytokines early after infection (2 hours) of Tlr23479 -/-mice ( Fig. 2 , C and D). In contrast, wt as well as Tlr23479 -/-mice and corresponding macrophages responded largely normally toward the same isolate grown in the absence of erythromycin (Fig. 2, C and D, and fig. S2, F to H) . The later (16 hours) increase and equalization of serum cytokine levels independent of erythromycin treatment ( fig. S2H ) suggested the loss of 23S rRNA methylation in the absence of erythromycin within the host. Together, these results demonstrate an erythromycin-driven camouflage of RNA from its receptor. Specifically, N 6 methylation of rRNA adenosine (A) 2085 in S. aureus (corresponding to E. coli A2058) by the erythromycin resistance methyltransferase (erm) B or ermC confers macrolide, lincosamide, and streptogramin group (MLS) antibiotic (that include erythromycin) resistance (17, 18) . Accordingly and also in line with inducibility of erm expression by erythromycin (17, 18) , 23S rRNA from S. aureus grown in erythromycin failed to stimulate Tlr23479 -/-macrophages (Fig. 2E ). In contrast, 23S rRNA from resistant S. aureus not grown in erythromycin and 23S rRNA from E. coli (including enterohemorrhagic Escherichia coli) activated Tlr23479 -/-macrophages, while the respective 16S RNAs failed to do so. (Fig. 2E, and fig. S2 , I and J). Moreover, overexpression of ermB and ermC (the latter being subcloned from cDNA of an erythromycin grown S. aureus isolate) in E. coli and B. subtilis strains conferred not only erythromycin resistance but also ablated 23S rRNA stimulatory activity ( Fig. 2F and fig. S2K ). These data indicated that resistance to MLS group antibiotics (including erythromycin) mediated by sitespecific methylation (targeting A2085 in S. aureus and A2058 in E. coli 23S rRNA) rendered 23S rRNA non-stimulatory.
To address the immune stimulatory activity of 23S rRNA in more detail, we designed three oligoribonucleotides (ORNs) as analogs of S. aureus 23S rRNA segments, each of which carries an A in its center that becomes methylated constitutively or under growth restriction to modulate the docking of protein synthesis cofactors or antibiotics. The three ORNs named SaI, SaII, and SaIII represented S. aureus A1662 (E. coli A1616, methylation of which promotes fitness (19)), S. aureus A2530 (E. coli A2503, targeted by chloramphenicol, florfenicol, and clindamycin resistance RNA methyltransferase (20) ), as well as S. aureus A2085 (E. coli A2058, modification of which costs fitness (17, 18, 21) , respectively (table S1) .
Only SaIII (which mirrors S. aureus A2085) activated Tlr23479 -/-cells (Fig. 3A) . pDCs recognized SaIII via TLR7, but this activity was lost with 3′-terminal deletion ( fig. S3 ). ORNs resulting from deletions of 3′-and 5′-termini (SaIIId3, SaIIId5, and Sa23) equally activated Tlr23479 -/-cDCs (Fig. 3B) , whereas preincubation of S. aureus RNA or of ORN Sa23 with an antisense SaIII RNA strand (SaIIIas) abrogated the stimulatory activity (Fig. 3C) . These results indicated single strand structure and singularity of the stimulatory activity within the bacterial transcriptome. Successive terminal deletions toward a 12-mer ORN (Sa12, table S1) led to sequences that were identical in S. aureus and E. coli 23S rRNAs. Length dependent reduction of stimulatory capacity could largely be compensated by terminal fill-ups (Sa12A19, Fig. 3D ) (22) . When Sa12 was N 6 -methylated at A6 (corresponding to S. aureus A2085 and mimicking erm-methylated 23S rRNA) it lacked stimulatory capacity, whereas N 6 -methylation at A7 merely caused a partial reduction (Fig.  3E) .
Consecutive single substitutions of Sa12 revealed "CGGAAAGACC" as the minimal stimulatory segment because ORNs with substitutions at position one or two of Sa12 (Sa12s1 and Sa12s2) were fully stimulatory whereas further substitutions resulted in drastic loss (Sa12s10 and Sa12s12) or abrogation of the stimulatory activity ( Fig. 3F and table S1 ).
In contrast, Sa12 derivatives mimicking eukaryotic 28S rRNA or specific 23S rRNA mutations that render bacteria resistant to MLS antibiotics (S. aureus 23S rRNA A2085G, mimicked by ORN Sa12s6G or Sa12s6U) failed to stimulate bone marrow cells (Fig. 3F and table S1 ) (18, 23) . These findings suggest that molecular mechanisms rendering bacteria resistant to naturally occurring antibiotics also impede MyD88 dependent host recognition by an ill-defined endosomal TLR.
To characterize the responsible TLR, we focused on TLR13, because analysis of Tlr8 -/-macrophages ruled out the involvement of TLR8. Specifically, wt and Tlr8 -/-macrophages exhibited comparable response to hiSa upon blockade TLR7, TLR9 and TLR2. Moreover, responsiveness to 23S rRNA-derived SaIII was similar ( fig. S4A) . Notably, siR-NA-driven suppression of TLR13 mRNA accumulation impaired the recognition of stimulatory ORNs such as SaIII by Tlr23479 -/-macrophages (Fig. 4A) . Although recognition of low doses of hiSa by Tlr23479 -/-macrophages treated with siRNA for TLR13 was strongly impaired, high dose hiSa challenge activated not only control but also TLR13 siRNA-treated cells, presumably via unsuppressed TLR13 molecules ( fig. S4B ). In addition, knock-down of MAPK1 mRNA indicated involvement of MAPK1 in TLR13-driven signal transduction (Fig. 4A  and fig. S4B ). Furthermore, ectopic expression of TLR13 but not of CD14, TLR3, -7, -8, -9 or -12 conferred responsiveness of HEK293 cells toward hiSa or the ORNs SaIII, Sa23, Sa17, or Sa12 (Fig. 4, B-D, and  fig. S4, C and D) . Other ORNs such as RNA40 (TLR7 ligand) or CpGcontaining oligodeoxynucleotides (ODNs, TLR9 ligands) were inactive (Fig. 4E) .
Having identified the conserved 23S rRNA sequence "CGGAAAGACC" as ligand for TLR13, we set out to evaluate its importance in vivo. Therefore we compared the cytokine storm induced by systemic application of TLR13 activating ORNs with that of TLR9 activating CpG-ODNs. Application of a nuclease resistant phosphorothioate Sa19 variant (Sa19 PSO) in vivo triggered systemic pro-inflammatory cytokine release similar to that elicited by the PSO-CpG oligonucleotide 1668 (Fig. 4F and fig. S4, E and F) . Consequently, systemic application of Sa19PSO to mice along with interferon-γ (IFN-γ) and Dgalactosamine (D-GalN) sensitization induced a fatal septic shock like syndrome in mice with functional TLR13 (wt and Tlr23479 -/-) whereas the 3D/Tlr24 -/-mice which lack responsiveness to TLR13 were resistant ( fig. S4G) , concordant with the genotype-selective fatal pathology elicited by systemic challenge with hiSa (Fig. 1F) . In contrast to the ORN Sa19, an ODN version of Sa19 (Sa19DNA, containing two CpG motifs), lacked TLR13 stimulatory activity, but activated TLR9 (fig. S4F ). All together, these data indicated that TLR13 functions as important bacteria sensor by recognizing an ssRNA segment within the peptidyl transferase loop of bacterial 23S rRNA that binds antibiotics of the MLS group.
Our data unravel an unanticipated link between antibiotic resistance and evasion from TLR13 recognition, because 23S rRNA modifications generating resistance toward MLS antibiotics also camouflaged bacteria from TLR13 recognition. MLS antibiotic-producing bacteria such as Saccharopolyspora erythraea were possibly first to express erms (to resist their own antibiotics) (17) . Erm expression plasmids might have been acquired from S. erythraea by staphylococci, pneumococci, and mycobacteria (which seem to accompany or even correlate with tuberculous property of the latter) (17, 24) . Even though macrolide resistance appears to be associated with fitness costs (21) , the pathogenic recipients did gain invisibility to TLR13. We therefore speculate that widespread ancient antibiotic resistance (25) has subverted TLR13 driven antibacterial immune resistance. This may explain why TLR13 expression has been abandoned in certain mammalian species, including human. If so, we anticipate that in human the function of TLR13 has been replaced by an RNA sensing PRR that is able to still recognize erythromycin resistance-forming RNA modifications. 
